BioWorld MedTech

July 7, 2015

Hansen gets bump to start ARTISAN: Hansen Medical completes enrollment in initial cohort of ARTISAN clinical trial

Coming off a 5.07% bump in its shares last week, intravascular robotics specialist Hansen Medical (NASDAQ: HNSN) (Mountain View, Calif.) said it has completed enrollment in the initial evaluable cohort of its ARTISAN clinical trial. Read More

Two patents invalidated: Fed Circuit: 'Experimental' manufacturing dooms patents

Latin America: British device aker looks to ride LatAm growth

Inside the Beltway: Economic impact report makes implicit argument for repeal of device tax

Report from Europe: EU Council readies CE mark reform for 'trialogue' negotiation

Daily M&A: Vygon Group buys Preouse to upgrade vascular access

Financings: Lantheus closes initial public offering,brings in nearly $66.7 million

World in Review: Lensar moves into Indian market, establishing Sharp Sight Centers

Products

Court Report: Enzo Biochem reaches $7.1M settlement with Luminex

People in Places

Briefly noted

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...